NRXS:NYSEMKT, NeurAxis, Inc.

Why NRXS stock fell on November 16

NeurAxis, Inc. fell 11.4% on Monday, November 16, 2026, on 521,278 shares, 3.9 times its average daily volume. No headline about NRXS came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

NRXS stock overview

NeurAxis, Inc. (NRXS:NYSEMKT) closed at $4.80 on November 16, 2026, down 11.44% on the day. The stock trades 48.6% below its 52-week high of $9.33 and 117.2% above its 52-week low of $2.21. Over the past year, it gained 100.0%. NeurAxis, Inc. is part of the Health Care sector.

Key figures

Price
$4.80
Day change
-11.44%
Volume
521,278
Average volume
135,210
Market cap
68M+
52-week range
$2.21 – $9.33
50-day average
$6.88
200-day average
$6.75

Price action over the past year

In 252 trading sessions since November 14, 2025, NRXS closed higher on 122 days (48%). Its best day was December 22, 2025 (+25.16%) and its worst was February 23, 2026 (-14.10%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

NRXS news

About NeurAxis, Inc.

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Similar stocks

Find more stocks like NRXS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.